Avance Clinical
Avance Clinical is a full-service Contract Research Organisation (CRO) headquartered in Australia, with extensive operations across North America, including its office in North Carolina, Asia and New Zealand. With more than 30 years of experience leading early phase clinical trials, it leverages the unique advantages of the Australian market, including rapid ethics approval, no IND requirement, and up to 43.5% off with the Australian R&D tax rebate, to provide biotechs with an accelerated pathway to clinical success.
Specialising in world-class operations, Avance Clinical guide biotechs from early pre-clinical development through to late-phase studies. With a focus on agility, innovation, and cost-effectiveness, it delivers fast results backed by robust, globally accepted data.
With expertise spanning over 250+ indications, across all therapeutic areas, over the last three decades, Avance Clinical consistently delivers data recognised by key global regulators, including the TGA, FDA, EMA, MHRA, MFDS, and PDMA.
What sets Avance Clinical apart is its personalised service tailored to each client, ensuring customised, flexible solutions rather than a one-size-fits-all approach.
Contact
Liahna Toy
Senior Vice President & Head of Early Phase Center of Excellence
Ben Edwards
Chief Operating Officer
Objectives
- Connecting with biotech innovators – engaging with biotech companies to explore tailored clinical trial solutions
- Showcasing Avance Clinical’s global services – highlighting ClinicReady (preclinical to Phase I consultancy), Australian advantage (early-phase trials with rapid start-up and rebate benefits), Asia advantage (expanding patient access and regulatory expertise in South Korea and Taiwan and beyond), GlobalReady (seamless transition from Phase I to Phase II proof-of-concept), and North America advantage (expert late-phase trial execution and patient access)
- Discussing the Australian advantage – explaining the benefits of conducting early-phase trials in Australia, including up to 43.5 per cent rebate and fast regulatory pathways
- Strengthening biotech partnerships – supporting biotech’s with strategic scientific and operational expertise across the company’s key regions
- Exploring emerging trends – staying ahead of biotech advancements to refine Avance Clinical’s clinical trial strategies and regulatory expertise
News
Early CRO is critical
Why early CRO choice is critical to accelerating delivery of your clinical program
Address preclincal package gaps
Accelerating development through parallel execution and rigorous quality controls
Appointment of Liahna Toy
Avance Clinical appoints Liahna Toy to lead global early phase Centre of Excellence
Accelerating early phase biotech trials
Avance Clinical launches dedicated Centre of Excellence to accelerate early phase biotech trials
Acquisition of US-based LumaBridge
Avance Clinical strengthens global oncology offering with acquisition of US based LumaBridge
Guiding 710 emerging biotechs
Avance Clinical accelerates time to pivotal milestones for more than 700 emerging biotechs
Navigate FDA's
Unlocking the potential of FDA expedited approval and voucher programs: An Avance Clinical partnership approach